methyl 2-(3-((N-(3-(2-amino-4-methyl-6-(pentylamino)pyrimidin-5-yl)propyl)-2-(4-hydroxypiperidin-1-yl)acetamido)methyl)phenyl)acetate | 1158802-32-4

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: methyl 2-(3-((N-(3-(2-amino-4-methyl-6-(pentylamino)pyrimidin-5-yl)propyl)-2-(4-hydroxypiperidin-1-yl)acetamido)methyl)phenyl)acetate
• 英文别名: Methyl 2-[3-[[3-[2-amino-4-methyl-6-(pentylamino)pyrimidin-5-yl]propyl-[2-(4-hydroxypiperidin-1-yl)acetyl]amino]methyl]phenyl]acetate
• CAS: 1158802-32-4
• 化学式: C₃₀H₄₆N₆O₄
• 分子量: 554.733
• InChiKey: FYRLAQZCQZFTDU-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.7
• 重原子数：
  40
• 可旋转键数：
  16
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.6
• 拓扑面积：
  134
• 氢给体数：
  3
• 氢受体数：
  9

文献信息

• [EN] PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF ASTHMA, COPD, ALLERGIC RHINITIS, ALLERGIC CONJUNCTIVITIS, ATOPIC DERMATITIS, CANCER, HEPATITIS B, HEPATITIS C, HIV, HPV, BACTERIAL INFECTIONS AND DERMATOSIS<br/>[FR] DÉRIVÉS DE PYRIMIDINE POUR LE TRAITEMENT DE L'ASTHME, DE LA BRONCHO-PNEUMOPATHIE CHRONIQUE OBSTRUCTIVE (COPD), DE LA RHINITE ALLERGIQUE, DE LA CONJONCTIVITE ALLERGIQUE, DE LA DERMATITE ATOPIQUE, DU CANCER, DE L'HÉPATITE B, DE L'HÉPATITE C, DU VIH, DU
  申请人：ASTRAZENECA AB

  公开号：WO2009067081A1

  公开（公告）日：2009-05-28

  The present invention provides compounds of formula (I) wherein R 1, R2, R3 and R4 are as defined in the specification, and pharmaceutically acceptable salts thereof, as well as processes for their preparation, pharmaceutical compositions containing them and their use in therapy.

  本发明提供了式（I）中的化合物，其中R1、R2、R3和R4如规范中定义，以及其药用盐，以及它们的制备方法、含有它们的药物组合物以及它们在治疗中的应用。
• NOVEL COMPOUNDS
  申请人：Bennett Nicholas J.

  公开号：US20130045955A1

  公开（公告）日：2013-02-21

  The present invention provides compounds of formula (I) herein R 1 , R 2 , R 3 and R 4 are as defined in the specification, and pharmaceutically acceptable salts thereof, as well as processes for their preparation, pharmaceutical compositions containing them and their use in therapy.

  本发明提供了公式（I）的化合物，其中R1、R2、R3和R4如规范中所定义，并且其药学上可接受的盐，以及它们的制备方法，含有它们的制药组合物和它们在治疗中的使用。
• Novel Compounds
  申请人：BENNETT Nicholas J.

  公开号：US20090209524A1

  公开（公告）日：2009-08-20

  The present invention provides compounds of formula (1) wherein R 1 , R 2 , R 3 and R 4 are as defined in the specification, and pharmaceutically acceptable salts thereof, as well as processes for their preparation, pharmaceutical compositions containing them and their use in therapy.

  本发明提供了式（1）的化合物 其中R1、R2、R3和R4如规范中所定义，并且其药学上可接受的盐，以及制备它们的方法，含有它们的制药组合物以及它们在治疗中的使用。
• PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF ASTHMA, COPD, ALLERGIC RHINITIS, ALLERGIC CONJUNCTIVITIS, ATOPIC DERMATITIS, CANCER, HEPATITIS B, HEPATITIS C, HIV, HPV, BACTERIAL INFECTIONS AND DERMATOSIS
  申请人：AstraZeneca AB

  公开号：EP2222648A1

  公开（公告）日：2010-09-01
• US8268990B2
  申请人：——

  公开号：US8268990B2

  公开（公告）日：2012-09-18